格隆汇1月6日丨Alterity Therapeutics(ATHE.US)盘前大涨近40%,报1.16美元,此前公司获得治疗神经退行性疾病的药物专利。 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-23-072649 Act: 34 Size: 203 KB 网页链接
$Alterity医疗(ATHE)$ 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)] Accession Number: 0001213900-23-072629 Act: 34 Size: 10 MB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-23-072564 Act: 34 Size: 54 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-23-070063 Act: 34 Size: 40 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-23-069642 Act: 34 Size: 37 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-23-067416 Act: 34 Size: 28 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-23-060991 Act: 34 Size: 434 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-23-059805 Act: 34 Size: 39 KB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-23-050719 Act: 34 Size: 20 MB 网页链接
$Alterity医疗(ATHE)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001213900-23-050225 Act: 34 Size: 26 KB 网页链接